Concepedia

Mélanie Gilet

MG

Statistics

Publications

2

Citations

40

H-Index

2

Active since

2021

Affiliations

Grand Charleroi Hospital(Current)

Cliniques Universitaires Saint-Luc

UCLouvain

Mélanie Gilet is an author at Grand Charleroi Hospital specializing in chemotherapy-induced immunogenic cell death, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

Publications per year

2021–2022

2

Publications

2

Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.

Marc Van den Eynde, Nicolas D. Huyghe, Astrid De Cuyper et al. · Journal of Clinical Oncology · 2021 · 30 citations · Full text

, , +17

Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

Nicolas D. Huyghe, Astrid De Cuyper, Isabelle Sinapi et al. · Journal of Clinical Oncology · 2022 · 10 citations · Full text

, , +17

1–2 of 2